A detailed history of Roxbury Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Roxbury Financial LLC holds 593 shares of BMY stock, worth $27,758. This represents 0.03% of its overall portfolio holdings.

Number of Shares
593
Previous 740 19.86%
Holding current value
$27,758
Previous $33.4 Million 4.16%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 05, 2026

SELL
$42.6 - $49.08 $6,262 - $7,214
-147 Reduced 19.86%
593 $32 Million
Q3 2025

Oct 01, 2025

SELL
$43.31 - $48.98 $7,665 - $8,669
-177 Reduced 19.3%
740 $33.4 Million
Q2 2025

Jul 07, 2025

SELL
$44.12 - $59.6 $4,412 - $5,960
-100 Reduced 9.83%
917 $42.4 Million
Q1 2025

Apr 09, 2025

BUY
$53.9 - $63.11 $377 - $441
7 Added 0.69%
1,017 $60.6 Million
Q4 2024

Jan 30, 2025

BUY
$51.92 - $59.94 $52,439 - $60,539
1,010 New
1,010 $59.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Roxbury Financial LLC Portfolio

Follow Roxbury Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roxbury Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roxbury Financial LLC with notifications on news.